Endocannabinoid/Endovanilloid System as New Therapeutic Target in Osteosarcoma

被引:0
|
作者
Rossi, F. [1 ]
Punzo, F. [2 ]
di Pinto, D. [1 ]
Pota, E. [1 ]
Barone, C. [1 ]
Manzo, I. [2 ]
Casale, F. [1 ]
机构
[1] Univ Naples 2, Della Donna Del Bambino E Chirurg Gen E Specialis, Naples, Italy
[2] Univ Naples 2, Med Sperimentale, Naples, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-0146
引用
收藏
页码:S127 / S127
页数:1
相关论文
共 50 条
  • [41] MODULATION OF THE ENDOCANNABINOID SYSTEM AS A POTENTIAL NEW TARGET IN THE TREATMENT OF SCHIZOPHRENIA
    Leweke, F. Markus
    Hellmich, Martin
    Pahlisch, Franziska
    Kranaster, Laura
    Koethe, Dagmar
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S47 - S47
  • [42] Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review
    Hryhorowicz, Szymon
    Kaczmarek-Rys, Marta
    Zielinska, Aleksandra
    Scott, Rodney J.
    Slomski, Ryszard
    Plawski, Andrzej
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [43] The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction
    Scherma, Maria
    Fadda, Paola
    Le Foll, Bernard
    Forget, Benoit
    Fratta, Walter
    Goldberg, Steven R.
    Tanda, Gianluigi
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2008, 7 (05) : 468 - 481
  • [44] The Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder?
    Kayser, Reilly R.
    Snorrason, Ivar
    Haney, Margaret
    Lee, Francis S.
    Simpson, H. Blair
    CANNABIS AND CANNABINOID RESEARCH, 2019, 4 (02) : 77 - 87
  • [45] Endocannabinoid system and mood disorders: Priming a target for new therapies
    Micale, Vincenzo
    Di Marzo, Vincenzo
    Sulcova, Alexandra
    Wotjak, Carsten T.
    Drago, Filippo
    PHARMACOLOGY & THERAPEUTICS, 2013, 138 (01) : 18 - 37
  • [46] Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies
    Karimi-haghighi, Saeideh
    Mahmoudi, Maedeh
    Sayehmiri, Fatemeh
    Mozafari, Roghayeh
    Haghparast, Abbas
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 951
  • [47] The endocannabinoid system: A new target for cardiometabolic risk reduction - Introduction
    Pepine, Carl J.
    Plutzky, Jorge
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (12A): : 1P - 2P
  • [48] ROLE OF THE ENDOVANILLOID/ENDOCANNABINOID SYSTEM IN THE MODULATION OF OSTEOCLAST ACTIVITY IN INDIVIDUALS WITH PAGET'S DISEASE OF BONE
    Paoletta, M. P.
    Liguori, S. L.
    Moretti, A. M.
    Iolascon, G. I.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S165 - S165
  • [49] mTOR: An attractive therapeutic target for osteosarcoma?
    Liu Ding
    Liu Congwei
    Qing Bei
    Yang Tao
    Wang Ruiguo
    Yu Heze
    Dou Bo
    Li Zhihong
    ONCOTARGET, 2016, 7 (31) : 50805 - 50813
  • [50] Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
    Maccarrone, Mauro
    Di Marzo, Vincenzo
    Gertsch, Jurg
    Grether, Uwe
    Howlett, Allyn C.
    Hua, Tian
    Makriyannis, Alexandros
    Piomelli, Daniele
    Ueda, Natsuo
    van der Stelt, Mario
    PHARMACOLOGICAL REVIEWS, 2023, 75 (05) : 885 - 958